Ashman
Claire Ashman, Stevenage GB
Patent application number | Description | Published |
---|---|---|
20090148905 | ANTIGEN-BINDING CONSTRUCTS - The invention relates to antigen-binding constructs comprising a protein scaffold which are linked to one or more epitope-binding domains wherein the antigen-binding construct has at least two antigen binding sites at least one of which is from an epitope binding domain and at least one of which is from a paired VH/VL domain, methods of making such constructs and uses thereof. | 06-11-2009 |
20100303821 | IMMUNOGLOBULINS - The present invention relates to antigen binding proteins to human IL-13, including anti-IL-13 antibodies and anti-IL-3/anti-IL-4 mAbdAbs, pharmaceutical formulations containing them and to the use of such antigen binding proteins in the treatment and/or prophylaxis of inflammatory diseases such as asthma or IPF. | 12-02-2010 |
20130142788 | HUMANISED ANTIGEN BINDING PROTEINS TO MYOSTATIN6 - The present invention relates to humanised antigen binding proteins, such as antibodies, which bind to myostatin, polynucleotides encoding such antigen binding proteins, pharmaceutical compositions comprising said antigen binding proteins and methods of manufacture. The present invention also concerns the use of such humanised antigen binding proteins in the treatment or prophylaxis of diseases associated with any one or a combination of decreased muscle mass, muscle strength and muscle function. | 06-06-2013 |
20140205604 | ANTIGEN BINDING CONSTRUCTS - The present invention is directed to antigen binding constructs comprising one or two epitope binding domains separated by a single chain Fc region of an antibody, wherein each epitope binding domain in capable of binding to VEGF, to dimers comprising two antigen binding constructs of the invention, pharmaceutical compositions comprising said dimers and their use in the treatment of diseases associated with VEGF signalling, such as diabetic macular edema (DME), wet age-related macular degeneration (Wet AMD). diabetic retinopathy, retinal vein occlusion (RVO), and corneal neovascularisation, and polynucleotide sequences encoding said antigen binding constructs. | 07-24-2014 |
Claire Ashman, Hertfordshire GB
Patent application number | Description | Published |
---|---|---|
20110008345 | ANTIGEN-BINDING CONSTRUCTS - The invention relates to antigen-binding constructs comprising a protein scaffold which are linked to one or more epitope-binding domains wherein the antigen-binding construct has at least two antigen binding sites at least one of which is from an epitope binding domain and at least one of which is from a paired VH/VL domain, methods of making such constructs and uses thereof. | 01-13-2011 |
20110256132 | MYOSTATIN BINDING PROTEINS - Description of antigen binding proteins, such as antibodies, which bind to myostatin, polynucleotides encoding such antigen binding proteins, pharmaceutical compositions comprising said antigen binding proteins and methods of manufacture. Furthermore, description of the use of such antigen binding proteins in the treatment or prophylaxis of diseases associated with anyone or a combination of decreased muscle mass, muscle strength and muscle function. | 10-20-2011 |
20120082682 | IL-13 BINDING PROTEIN - The present invention relates to antigen binding proteins to human IL-13, including anti-IL-13 antibodies and anti-IL-3/anti-IL-4 mAbdAbs, pharmaceutical formulations containing them and to the use of such antigen binding proteins in the treatment and/or prophylaxis of inflammatory diseases such as asthma or IPF. | 04-05-2012 |
Daniel N. Ashman, Montrose CA
Patent application number | Description | Published |
---|---|---|
20090102622 | APPARATUS AND METHOD FOR REMOTE MONITORING AND DEACTIVATION OF AN ASSET - There is disclosed an apparatus for remotely and controllably deactivating or partly deactivating a first asset, which first asset may comprise an air dependent power source. The apparatus may comprise a regulator associated with the first asset. The regulator may comprise a valve having first and second positions and the first position may allow a first rate of the air supply to the power source and the second position may allow a second rate of air supply to the power source and the second rate may be less than the first rate. The apparatus may further comprise a controller remote from the regulator for transmitting a control signal to the regulator; the valve being actuable in response to the control signal to move between the first and second positions thereby regulating the air supply to the power source. | 04-23-2009 |
20090231089 | APPARATUS AND METHOD FOR REMOTE MONITORING AND DEACTIVATION OF AN ASSET - An apparatus is disclosed for remotely and controllably deactivating or partly deactivating a first asset, which first asset may comprise an air dependent power source. The apparatus may comprise a regulator associated with the first asset. The regulator may comprise a valve having first and second positions and the first position may allow a first rate of the air supply to the power source and the second position may allow a second rate of air supply to the power source and the second rate may be less than the first rate. The apparatus may further comprise a controller remote from the regulator for transmitting a control signal to the regulator; the valve being actuable in response to the control signal to move between the first and second positions thereby regulating the air supply to the power source. | 09-17-2009 |
Danny N. Ashman, Montrose CA
Patent application number | Description | Published |
---|---|---|
20130204462 | METHOD FOR CONTROLLED AND SAFE POWERING DOWN OF AUTONOMOUS POWER UNIT SYSTEMS USING A SUB-HERTZ PULSE-GATING TECHNIQUE - A method for powering down a autonomous power unit includes a spark ignition engine power source having an associated power source actuating system and a power output, comprises a regulator associated with the power source. The regulator comprises a deactivator actuatingly linked to the power source actuating system and having a base and secondary configurations wherein the base configuration allows the rated power output by the power source and the secondary configurations allow a progressively reduced secondary rate of power output by the power source and wherein the secondary rates are less than the base rate. The apparatus further comprises a controller remote from the regulator, for transmitting a control signal to the regulator. The deactivator is actuable in response to the control signal to activate either the base rate configuration or one of the secondary configurations to control thereby regulating the power source. | 08-08-2013 |
Elizabeth Ashman, Cardiff, South Glamorgan GB
Patent application number | Description | Published |
---|---|---|
20150299770 | Methods for One Step Nucleic Acid Amplification of Non-Eluted Samples - The present invention relates to methods and kits which can be used to amplify nucleic acids with the advantage of decreasing user time and possible contamination. For easy processing and amplification of nucleic acid samples, the samples are bound to a solid support and used directly, without purification, in a nucleic acid amplification reaction such as the polymerase chain reaction (PCR). | 10-22-2015 |
Keith Ashman, North Ryde AU
Patent application number | Description | Published |
---|---|---|
20140156206 | Detection and Quantification of Polypeptides Using Mass Spectrometry - The invention relates to the detection and quantification of polypeptides using mass spectrometry. Specifically, the invention provides a method for testing whether a target polypeptide is present in a sample of a set of polypeptides, a method for deriving a value for distinguishing polypeptides of a set of polypeptides from each other, a database containing values for distinguishing each polypeptide of a set of polypeptides from each other, and an apparatus for configuring a mass scan of a mass spectrometer to test whether a target polypeptide of a set of polypeptides is present in a sample of the set. | 06-05-2014 |
Keith Ashman, New South Wales AU
Patent application number | Description | Published |
---|---|---|
20100299081 | Detection and Quantification of Polypeptides Using Mass Spectrometry - The invention relates to the detection and quantification of polypeptides using mass spectrometry. Specifically, the invention provides a method for testing whether a target polypeptide is present in a sample of a set of polypeptides, a method for deriving a value for distinguishing polypeptides of a set of polypeptides from each other, a database containing values for distinguishing each polypeptide of a set of polypeptides from each other, and an apparatus for configuring a mass scan of a mass spectrometer to test whether a target polypeptide of a set of polypeptides is present in a sample of the set. | 11-25-2010 |
Peter Ashman, Walkerville AU
Patent application number | Description | Published |
---|---|---|
20150054284 | HYBRID RECEIVER-COMBUSTOR - A hybrid receiver-combustor ( | 02-26-2015 |
Philip Ashman, Gennevilliers FR
Patent application number | Description | Published |
---|---|---|
20150013818 | Multilayer Film for a Skirt of a Flexible Tube and Associated Flexible Tube - The invention proposes a film ( | 01-15-2015 |
Philip Colin Ashman, Essex GB
Patent application number | Description | Published |
---|---|---|
20100279046 | COLLAPSIBLE TUBE CONTAINERS - The present invention relates to collapsible tube containers formed from blown film polymeric material or blown film multi-layer polymeric materials, and in particular collapsible tube containers comprising a side-seam weld or join. Each layer of the multi-layer polymeric material benefits from a substantially similar or balanced molecular orientation profile. The present invention also relates to a method of forming a collapsible tube container from blown film polymeric material or blown film multi-layer polymeric materials, the tube comprising a side seam-weld or join. | 11-04-2010 |
Stephen Ashman, Stevenage GB
Patent application number | Description | Published |
---|---|---|
20130142788 | HUMANISED ANTIGEN BINDING PROTEINS TO MYOSTATIN6 - The present invention relates to humanised antigen binding proteins, such as antibodies, which bind to myostatin, polynucleotides encoding such antigen binding proteins, pharmaceutical compositions comprising said antigen binding proteins and methods of manufacture. The present invention also concerns the use of such humanised antigen binding proteins in the treatment or prophylaxis of diseases associated with any one or a combination of decreased muscle mass, muscle strength and muscle function. | 06-06-2013 |